Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 2 9Phase 1 5Phase 4 4Phase 2/3 2Phase 1/2 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 91Neoplasms 75Prostatic Neoplasms 54Carcinoma, Hepatocellular 53Colorectal Neoplasms 49Leukemia, Myeloid, Acute 41Stomach Neoplasms 36Carcinoma, Non-Small-Cell Lung 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 29Pancreatic Neoplasms 27Lung Neoplasms 26Rectal Neoplasms 23Multiple Myeloma 21Hematologic Neoplasms 21Head and Neck Neoplasms 20Colonic Neoplasms 20Recurrence 19Lymphoma 19Leukemia 19Polycystic Ovary Syndrome 16Liver Neoplasms 14Esophageal Neoplasms 14Brain Neoplasms 13Myelodysplastic Syndromes 12Melanoma 12Endometrial Neoplasms 12Uterine Cervical Neoplasms 11Motor Activity 11Fatigue 11

Interventions

pembrolizumab 1Gemcitabine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Klatskin Tumor × Clear all
NCT06923475 2025-04-11

NEODISCO

Amsterdam UMC, location VUmc

Phase 2/3 Not yet recruiting
150 enrolled
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT02108145 2019-08-01

Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

Air Force Military Medical University, China

Phase 2/3 Unknown
70 enrolled
Gastrointestinal

Jaundice, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡